FDA clears IDX image management system

Article

The Food and Drug Administration has given the regulatory greenlight to IDX Systems for its IDXview image management product.IDXview represents the Burlington, VT, company's effort to expandfrom its base in radiology information systems into digital

The Food and Drug Administration has given the regulatory greenlight to IDX Systems for its IDXview image management product.IDXview represents the Burlington, VT, company's effort to expandfrom its base in radiology information systems into digital imagemanagement, according to Britt Cummings, manager of radiologysystems.

IDXview is based on Digital Equipment Alpha workstation architecturerunning an X-Windows operating system with 1k x 1k display monitors.It is DICOM-compliant and can be integrated with the company'sIDXrad RIS product, making it one of the first commercially availableintegrated RIS/image management solutions.

IDXview is not a PACS product, Cummings said, because it lacksthe 2k x 2k monitor technology required for primary diagnosis.Instead, IDX will market the system as ideal for consultationand review between radiology departments and referring physiciansin other areas. A primary diagnosis component can be added vialinks to PACS products from other vendors, he said.

IDX will emphasize the integrated nature of the RIS and imagemanagement system in marketing IDXview. IDXrad has a sophisticatedsearch engine that makes it easy for physicians to locate andsort patient data, according to Cummings.

"Because we are so tied to the RIS, we have some verysimple and efficient searches to find the patient (physicians)are looking for," Cummings said.

There are two beta sites using IDXview and the company is readyto begin shipping the product.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.